Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Neurology: Neuroimmunology and NeuroInflammation is Scopus-indexed (Q1, CiteScore 13.3), WoS SCIE, DOAJ. It is covered by India's One Nation One Subscription scheme, which pays the article processing charge for authors at eligible institutions. Published by Lippincott Williams and Wilkins.
Checked against the index lists dated .
ISSN 2332-7812Verify ISSN ↗
Publisher: Lippincott Williams and Wilkins
Cost to publish: APC covered for authors at ONOS-subscribed Indian institutions
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Neurology | 7 / 201 | 96th | Q1 |
| Neurology (clinical) | 18 / 403 | 95th | Q1 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas
Yes — actively indexed in Scopus, coverage 2014–present, best quartile Q1, CiteScore 13.3.
Neurology: Neuroimmunology and NeuroInflammation is Q1 in Neurology (rank 7 of 201) and Q1 in Neurology (clinical) (rank 18 of 403), by CiteScore 2025.
Neurology: Neuroimmunology and NeuroInflammation is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 13.3, which places it in quartile Q1 at the 96th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.400, quartile Q1, with an H-index of 86.
For authors at Indian institutions covered by One Nation One Subscription (ONOS), the article processing charge is paid by the scheme. The publisher lists an article processing charge of about US$3,450 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Neurology: Neuroimmunology and NeuroInflammation is published by Lippincott Williams and Wilkins. Its ISSN is 2332-7812.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS also covers its article processing charge for authors at eligible institutions.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Neurology: Neuroimmunology and NeuroInflammation has an h-index of 102 and a 2-year mean of 6.95 citations per paper (OpenAlex). Its Scopus CiteScore is 13.3, quartile Q1. On 2-year citations it ranks #10 of 201 Scopus journals in Neurology.
Neurology: Neuroimmunology and NeuroInflammation published 149 papers in 2025; its busiest recent year was 2020 with 205. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 92 research articles (2026), authors are most often from United States (23.4%), Italy (15.8%) and Germany (13.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.